DISCONTINUED Doxepin Hydrochloride
It was noted in the March Pharmaceutical Schedule Update that Mylan, the supplier of doxepin hydrochloride capsules, had notified PHARMAC that ANTEN CAPSULES have been discontinued internationally by their manufacturer.
Stock remains available at present so there is no immediate cause for concern. However you will need to discuss with patients as we move closer to stock being depleted and delisting which will occur at varying times as follows:-
Anten Cap 10 mg 100 Pharmacode 589209 Anticipated stock depletion July 2019 Delisting 1 January 2020
Anten Cap 25 mg 100 Pharmacode 348554 Anticipated stock depletion November 2019 Delisting 1 April 2020
Anten Cap 50 mg 100 Pharmacode 348570 Anticipated stock depletion November 2019 Delisting 1 May 2020
Anticipated stock depletion is based on current sales rates.
There is no other brand registered in New Zealand.
An Endorsement has been placed on doxepin hydrochloride, effective 1 March 2019 meaning no new patients can be initiated on doxepin capsules.
We thank you in anticipation of your ongoing support.